BlackRock TCP Capital Corp. Q3 2026 Earnings Call - BLACKROCK TCP CAPITAL CORP

Explicit Guidance:

• No formal quantitative guidance provided for future revenue, earnings, margins, capex, or dividends.
• Declared Q4 2026 dividend of $0.17 per share, payable December 31, 2026 (record date December 17, 2026).
• Board will continue to evaluate the dividend amount pending the conclusion of the strategic review.
• Adjusted net investment income (non-GAAP) guidance is absent; current run-rate noted at $0.15 per share (annualized) for Q3 2026.

Business-Segment Outlook:

• Portfolio Composition: Future investment activity expected to maintain a "more granular portfolio focused on the top of the capital stack" if the company resumes origination post-strategic review.
• Asset Concentration: Largest investment (36th Street Capital) currently represents 19.3% of the portfolio; no specific timeline or plan provided for reducing this concentration other than general portfolio restructuring.
• Investment Volume: New investment activity is expected to remain limited to "follow-on investments in existing portfolio companies" until the strategic review concludes.
• Non-Accruals: Current non-accrual level at 3.4% of portfolio fair value (14.2% at cost); management anticipates portfolio size reduction via repayments/sales to normalize these percentages, though no specific future target is cited.

Market and Competitive Outlook:

• No specific commentary on pricing trends, supply chain shifts, or competitive share changes beyond the strategic decision to maintain "liquidity and flexibility" in response to market uncertainty and the ongoing review.
• Management indicates no immediate pursuit of new deployment opportunities, prioritizing optionality over market expansion during the review period.

Macro / Industry Outlook:

• No specific management views provided on broader economic conditions, interest rates, FX, or regulatory changes, aside from the implicit context of the strategic review driven by current market performance (NAV decline).

Strategic Initiatives:

• Strategic Review: Board has engaged Keefe, Bruyette & Woods to review strategic alternatives; no definitive outcome or timeline (Q4 2026 vs. H1 2027) has been disclosed.
• Continuation Vehicle Transaction: Completed sale of $524 million of investments to a Pantheon-sponsored vehicle; $405 million of CLO debt assumed by the vehicle (completed Q3 2026).
• Capital Preservation: Deliberate decision to maximize cash on hand to preserve optionality for the Board; no long-term intention to hold elevated cash levels.
• Potential Actions: If the business continues as an independent entity, capital could be deployed via stock buybacks or resumption of origination activities, subject to Board finalization.

Risks and Headwinds to Outlook:

• Strategic Review Uncertainty: No definitive timeline for the review outcome creates uncertainty regarding future deployment, capital allocation, and dividend sustainability.
• NAV Volatility: Portfolio valuation remains sensitive to "job and talent" (specifically regarding their own strategic alternatives) and market markdowns; previous markdowns contributed $0.15 per share to NAV decline.
• Concentration Risk: High concentration in 36th Street Capital (19.3%) and reduced diversification post-sale.
• Dividend Coverage: Adjusted net investment income ($0.15/share) trailed the declared dividend ($0.17/share) in Q3 2026; continued coverage dependent on the review outcome and portfolio performance.

Management Tone on the Future:

• Cautious and Preservative: Tone reflects a "wait-and-see" approach; explicitly states they do not intend to hold high cash levels long-term but prioritize preserving "all alternatives available to the Board."
• Ambiguity on Timing: Management avoided speculating on the conclusion of the strategic review, stating the timeline is "TBD" and they are balancing efficiency with thoroughness.
• Confidence in Process: Reiterated focus on maximizing shareholder value through the review, but offered no confidence in specific future financial metrics or re-deployment schedules.

Miscellaneous:

• Liquidity Position: Quarter-end cash balance $253 million plus $258 million available revolver capacity (Total liquidity $511 million).
• Leverage: Net regulatory leverage reduced to 0.16x (down from 0.40x pro forma post-continuation transaction); total debt-to-equity at 0.7x.
• Debt Structure: Outstanding debt is unsecured, non-callable, with a weighted average interest rate of 6.9%.